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differentiating cells produced and
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SUMMARY

Terminal differentiation is essential for the development and maintenance of tissues in all multi-cellular organisms and is associated with permanent exit from the cell cycle. Failure to permanently exit the cell cycle
can result in cancer and disease. However, the molecular mechanisms and timing that coordinate differentiation commitment and cell cycle exit are not yet understood. Using live, single-cell imaging of cell cycle progression and differentiation commitment during adipogenesis, we show that a rapid switch mechanism
engages exclusively in G1 to trigger differentiation commitment simultaneously with permanent exit from
the cell cycle. We identify a molecular competition in G1 between when the differentiation switch is triggered
and when the proliferative window closes that allows mitogen and differentiation stimuli to control the balance between terminally differentiating cells produced and progenitor cells kept in reserve, a parameter of
critical importance for enabling proper development of tissue domains and organs.

INTRODUCTION
Terminal differentiation is essential for developing, maintaining,
and regenerating tissues in humans and other multi-cellular organisms and is the mechanism by which neurons, skeletal muscle cells, adipocytes (fat cells), and many other critical cell types
are generated (Ruijtenberg and van den Heuvel, 2016). Terminal
differentiation typically requires that proliferative progenitor cells
permanently exit the cell cycle. Failure of terminally differentiated
cells to permanently exit the cell cycle can lead to disease and is
a hallmark of cancer (Ghaben and Scherer, 2019; Ruijtenberg
and van den Heuvel, 2016). However, despite the fundamental
importance of coordinating terminal cell differentiation with permanent cell cycle exit, whether, how, and when this occurs has
not been clear (Buttitta and Edgar, 2007; Hardwick et al., 2015;
Soufi and Dalton, 2016).
A main bottleneck in understanding the relationship between
cell cycle exit and terminal differentiation is the great variability
in whether and when individual progenitor cells in the same population proliferate or differentiate during the several-day-long differentiation process, making it difficult to answer timing questions using traditional bulk cell approaches. To overcome this
challenge, methods are needed that can simultaneously track
cell cycle and differentiation progression live in individual cells
in order to measure whether and when during the multi-day differentiation time course an individual cell commits to irreversibly
differentiate. However, such live-cell imaging studies for terminal
cell differentiation have to our knowledge not yet been made.

Here we sought to understand the molecular mechanisms underlying when and how cells coordinate the commitment to
terminally differentiate and exit the cell cycle and how such coordination may control the number of terminally differentiated
cells produced. We use adipogenesis as a model system for terminal differentiation because the cell cycle is known to regulate
adipogenesis, and the validity of using in vitro cell models for adipogenesis studies has been corroborated by in vivo studies
(Ghaben and Scherer, 2019; Jeffery et al., 2015; Tang et al.,
2003). We start by validating that a threshold level of fluorescently tagged endogenous PPARG protein can be used in live
cells to mark the precise time when preadipocytes irreversibly
commit to terminally differentiate. By combining this live-cell
PPARG sensor with a reporter to mark the G1 phase (SakaueSawano et al., 2008), we establish a method to simultaneously
track both cell cycle progression and the precise commitment
point to terminally differentiate. Markedly, we show that cells
commit to terminally differentiate exclusively in G1 by triggering
a PPARG-driven switch and that this same switch also triggers
permanent cell cycle exit by rapidly inducing high expression
and increased stability of the CDK inhibitor p21. Thus, cells
become post-mitotic precisely when they commit to terminally
differentiate. Importantly, we show that after a differentiation
stimulus has been added, cells undergo a competition during
each G1 period between whether a cell starts the next cell cycle
or, alternatively, terminally differentiates and permanently stops
future cell divisions. We show that the levels of p21 and cyclin D,
as well as the mitogen and adipogenic stimuli that induce

Cell Reports 31, 107769, June 16, 2020 ª 2020 The Author(s). 1
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

ll
OPEN ACCESS

expression of these proteins, influence the outcome of this
competition by controlling the duration of G1, as well as the
rate of PPARG increase, during G1. The existence of this competition in G1 means that the cell is able to control both the number
of terminally differentiated cells produced and the number of
progenitor cells that are kept in reserve. Thus, G1 competition
represents a control principle that can explain how a tissue
can regulate the number of terminally differentiated cells produced while maintaining pools of progenitor cells at similar
levels.
RESULTS
Development of a Live-Cell Readout for the Precise
Time When a Cell Commits to Terminally Differentiate
A major limiting factor in understanding the relationship between
the cell cycle and terminal differentiation has been the lack of a
quantitative live-cell readout that can mark the precise time point
when a cell commits to terminally differentiate (Buttitta and
Edgar, 2007). We thus started by establishing such a live-cell
readout. During adipogenesis, expression of PPARG, the master
transcriptional regulator of adipogenesis, is driven by both
external input signals and internal positive feedback loops (Ahrends et al., 2014; Rosen and Spiegelman, 2014) (Figure 1A,
top). Previously, we had used CRISPR-mediated genome editing
to tag endogenous PPARG with citrine(YFP) fluorescent protein
in an OP9 preadipocyte cell line (Figure 1A, bottom) (BahramiNejad et al., 2018). We now validate that a threshold in PPARG
levels can be used as a live-cell readout for the precise time
when a cell commits to terminally differentiate.
To determine whether there is a threshold for differentiation, it
is critical to remove the differentiation stimulus at an intermediate
time point and test whether a cell can continue on to reach and
maintain a distinct differentiated state days later (Bahrami-Nejad
et al., 2018). We induced differentiation by applying the standard
DMI adipogenic hormone cocktail that mimics glucocorticoids
and GPCR signals that raise cAMP to preadipocytes for 48 h
(see STAR Methods). The distribution of PPARG levels at the
end of the 96 h differentiation protocol is bimodal, with high
and low peaks representing the differentiated and undifferentiated cells, respectively (Figures 1B and 1C). Comparing each
cell’s PPARG level at 96 h with its PPARG level at 48 h before
the stimulus was removed showed that the level of PPARG
before stimulus removal could indeed predict, with a less than
5% false positive rate, whether a cell would go on to differentiate
2 days later, confirming that a threshold level in PPARG can predetermine the cell’s final fate (Figures 1C and S1A–S1C). This
threshold level is calculated at the end of each experiment as
the center between the two peaks in the PPARG histogram at
the 48 h time point (Figures 1B and 1C, black dashed line; see
STAR Methods).
We validated that cells with PPARG levels above the threshold
are in the differentiated adipocyte state by using different wellestablished markers of mature adipocytes (Figure 1D). Furthermore, we showed that PPARG levels are predictive of final fate
independently of when cells pass the threshold for terminal differentiation and that cells with higher PPARG levels maintain a
higher probability to differentiate at different time points
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throughout adipogenesis (Figure 1E). Interestingly, the probability to differentiate could not be predicted by PPARG levels at the
start of the experiment (Figure 1E), suggesting that terminal differentiation fate is determined mostly by differences in signaling
strength rather than initial PPARG expression.
Previous work showed that a positive feedback-driven bistable
switch mechanism between PPARG and several co-regulators
can amplify PPARG expression (Ahrends et al., 2014; Wu et al.,
1999) (Figure 1A, top). To determine whether such a positive feedback-driven bistable switch is responsible for cells to reach the
PPARG threshold, we computationally aligned single-cell traces
to the time when each cell crosses the PPARG threshold. Markedly, the aligned time courses show a sharp sigmoidal increase
from a slow rate of PPARG increase before the PPARG threshold
to a fast rate after that time point (Figures 1F and S1D). This
observed switch from low to high PPARG levels exactly at the
time point at which the PPARG threshold is reached argues that
the PPARG threshold marks the precise time point when the bistable PPARG switch mechanism is triggered.
Early in adipogenesis, before cells reach the threshold,
PPARG levels are not correlated with endpoint measurements
of adipocyte markers (Figure 1G). However, once the threshold
is reached, PPARG levels sharply switch to being positively
correlated, supporting that crossing the PPARG threshold marks
a short time window of PPARG self-amplification that causes an
irreversible commitment to the future terminally differentiated
adipocyte state (see also Figures S1D and S1E). Taken together,
these different experiments validate that a threshold level can be
used to mark a precise timepoint when progenitor cells commit
to terminally differentiate, even before the markers of mature
fat cells can be measured. When adipogenic stimuli are
removed, cells that pass the PPARG threshold go on to terminally differentiate, while cells below the threshold return to the
undifferentiated progenitor state (Bahrami-Nejad et al., 2018).
Thus, fluorescently tagged endogenous PPARG can be used
to directly address the questions of when a cell commits to terminally differentiate and what the connection is between the
commitment to terminally differentiate and permanent exit from
the cell cycle.
Simultaneous Single-Cell Analysis Shows that Further
Entry into the Cell Cycle Is Blocked Once a Cell Reaches
the Differentiation Commitment Point in G1
We next made a dual-reporter cell line by transfecting a FUCCI
cell cycle reporter (Sakaue-Sawano et al., 2008) into the
citrine-PPARG preadipocyte cell line described in Figure 1A (Figure 2A; Videos S1 and S2). The fluorescent mCherry(RFP) signal
of the cell cycle reporter (hereafter referred to as the APC/C reporter) rapidly drops in mitosis and starts to increase only close
to the end of G1 phase, when the second APC/CCDH1, which is
active during G1, is rapidly inactivated (Cappell et al., 2016). To
determine when terminal cell differentiation occurs relative to
the cell cycle, we tracked PPARG expression and APC/C reporter time courses over 4 days of differentiation. The resulting
cell trajectories show that cells that go on to terminally differentiate have fewer cell cycles and exit the last mitosis earlier (Figures 2B and 2C) compared with cells that do not end up differentiating. Such an inverse relationship between proliferation and
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Figure 1. Live-Cell Analysis of Endogenous PPARG Expression Shows that There Is a Precise Time When Cells Irreversibly Commit to
Differentiate
(A) Cells expressing endogenous citrine-PPARG were differentiated using the standard 96 h DMI protocol. Scale bar, 50 mm.
(B) Results of a typical experiment in which thousands of single cells were stimulated to differentiate. In the standard 96 h DMI differentiation protocol, an
adipogenic cocktail (DMI) is added to the cell medium for 48 h (green horizontal bar). Then the medium is replaced with fresh medium containing just insulin for
another 48 h (grey horizontal bar). Thirty single-cell traces are shown as examples. Representative of four biological replicates.
(C) Scatterplot using data from (B) showing PPARG levels for each cell at 48 h, just before the DMI stimulus was removed, and at 96 h.
(D) Citrine-PPARG cells were differentiated using the DMI protocol, and immunocytochemistry for adipocyte markers was performed at 96 h (for each scatterplot,
n > 4,000 cells, representative of three biological replicates).
(E) The time courses from (B) were split into equal-width bins by their PPARG values at 0, 24, 48, and 72 h. The fraction of differentiated cells represents the
number of cells that crossed the PPARG threshold at the end of the experiment divided by the number of cells in the bin.
(F) Differentiating cells from (B) were computationally aligned so that the zero time point represents the time when the cell crossed the PPARG threshold. Plot
shows five representative single-cell traces, the median (solid black line), and the 5th to 95th percentiles (shaded region).
(G) PPARG time courses from the cells that differentiated after 96 h in (D) were computationally aligned as in (F) and plotted (blue curves). At each aligned time
point, the Pearson correlation coefficient between the aligned PPARG values and the endpoint immunofluorescence values for adipocyte markers was calculated
(red curves). As a comparison, PPARG values for the Glut4 panel were aligned to a randomized PPARG threshold crossing point. The randomized crossing point
was generated by scrambling the vector of measured threshold points for each cell so that each threshold point is matched with different cell.
In (B)–(F), the dotted line represents the calculated PPARG threshold for that experiment. Cells with PPARG levels above and below the threshold level are defined
to be differentiated (PPARG High) and undifferentiated (PPARG Low), respectively.
See also Figure S1.

terminal differentiation can be represented in a cumulative plot
comparing the percentage of cells still in S/G2/M versus the percentage of cells that have crossed the PPARG threshold for terminal differentiation, as a function of time after DMI stimulation
(Figure 2D). Control experiments that characterized the cell
plating conditions used (Figures S3A and S3B) support that the
lower differentiation we observed in cycling cells is not due to

PPARG levels simply being diluted more in cells that cycle
more often (Figures S3C and S3D).
Strikingly, when visually inspecting thousands of single-cell
traces in preadipocytes induced to differentiate, we observed
no new cell cycle entry after the PPARG level in a cell increased
above the threshold for terminal differentiation (Figure 2E, yellow
dot), arguing that permanent cell cycle exit is forced on cells
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Figure 2. Cells Commit to Terminally Differentiate Exclusively during G1 Phase
(A) Dual-reporter cells stably expressing APC/C-reporter-mCherry(RFP) and citrine(YFP)-PPARG. Anaphase is shown both by a split in the H2B-mTurquoise signal
(top images) and by a sharp drop in APC/C reporter signal (bottom time course). White outlines mark the position of nuclei in cells after anaphase. Scale bar, 20 mm.
(B) Cells were induced to differentiate using the standard 96 h DMI protocol. The dual-reporter cells allow simultaneous measurement in thousands of single cells
of differentiation state using PPARG levels (left) and cell cycle state using the APC/C sensor (right). The time points at which mitosis occurred were determined by
using the split in H2B signal (black open circles). Representative of four biological replicates.
(C) Comparison of the number of observed mitotic events that occurred in cells that were differentiated versus cells that remained undifferentiated at the end of
the 96 h experiment shown in (B).
(D) Plot showing how the fraction of cells in S/G2/M (red) or with PPARG levels higher than the threshold (blue) varies during a 96 h differentiation time course
induced by DMI.
(E) Examples of PPARG (blue) and APC/C reporter (red) time courses obtained in the same single cell. Cells were stimulated to differentiate using the standard
96 h DMI protocol. The yellow dot in each plot marks the time at which that cell reached the PPARG threshold and irreversibly committed to the differentiated
state. Bottom row shows examples of three undifferentiated/proliferating cells and one undifferentiated/quiescent cell that no longer proliferates even after a
serum refresh at 48 h.
(F) Histogram of the difference between the time when the PPARG threshold is crossed and when mitosis last occurred for each cell in the experiment shown in
(B). The PPARG threshold is reached on average 14 h after the last mitosis is completed. The median value is 11 h. Negative values indicate cells that reached
the PPARG threshold before the last mitosis was completed.

(legend continued on next page)
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when they reach the commitment point to terminally differentiate. We observed that in many cells, PPARG levels increase
already during S/G2/M phase, but cells reach the PPARG
threshold for terminal differentiation almost exclusively in G1
phase (see also Figures S3E and S3F). A histogram analysis
shows that a cell needs approximately 14 h in G1 phase after
the last mitosis to commit to the terminally differentiated state
(Figure 2F). It should be noted that our live dual-reporter method,
with which we can measure cell cycle and differentiation progression simultaneously, allows us to distinguish between cells
that become (1) post-mitotic and differentiated, (2) undifferentiated and proliferating, or (3) undifferentiated and quiescent (Figure 2G). As an example of a quiescent cell, the bottom right plot
in Figure 2E shows a cell that remains undifferentiated but
ceases to proliferate even when serum is refreshed at 48 h.
An interesting result from this analysis is that preadipocytes undergo a variable number of cell divisions before they differentiate
(Figures 2C and 2E), arguing that terminal differentiation of adipocytes does not occur after a fixed number of cell divisions before
differentiation, as has been previously suggested (Tang et al.,
2003). As the previous study relied on averaged, populationbased measurements, the variable number of mitoses in different
cells could likely not be resolved without live single-cell analysis.
Not only does the number of cell cycles vary, but there is also
great variability in the time after stimulation when cells start to increase PPARG levels, and also in the time cells spend in G1
before cells reach the PPARG threshold for terminal differentiation (see also Figure S4). Taken together, our results show that
terminal adipocyte differentiation occurs after a variable rather
than fixed number of cell cycles and that cells commit to differentiate almost exclusively during G1 phase. Furthermore, the time
cells need in G1 to reach the differentiation commitment point
is variable, and during S/G2/M, PPARG increases are suppressed. Strikingly, our dual-reporter timecourses show that cells
permanently exit the cell cycle at precisely the same time when
they pass the commitment point for terminal differentiation.
PPARG Regulates Terminal Cell Cycle Exit by Inducing
p21 and FKBPL
The dual-reporter time courses in Figures 2B–2E showed that
DMI-stimulated cells that stopped proliferating earlier also had
consistently higher levels of PPARG, supporting that PPARG
may suppress the cell cycle and also regulate permanent cell cycle exit. To test for this, we carried out small interfering RNA
(siRNA) experiments which showed that depletion of PPARG
indeed results in an increase in the percentage of proliferating
cells at all time points throughout the differentiation process (Figure 3A). On the basis of our observation that differentiation
commitment occurs almost exclusively in G1 phase (Figures
2E and 2F) and out of a state with low CDK2 activity (Figures
S3E and S3F), we hypothesized that PPARG may increase the
expression of one of the CDK inhibitors, which may then slow
or inhibit entry into the next cell cycle.

OPEN ACCESS

We sought to identify putative inhibitors of proliferation by performing comparative RNA sequencing (RNA-seq) analysis using
cells transfected with siRNA targeting PPARG or control siRNA
and collected at different time points during a 144 h DMI
differentiation protocol. When we examined mRNA expression
profiles of canonical CDK inhibitors, we identified two that
were strongly regulated by PPARG expression, p18 and p21
(Figure 3B). To determine whether p18 and p21 mediate cellcycle arrest during adipogenesis, we carried out siRNA experiments and found that p21, but not p18, knockdown leads to an
increase in proliferation (Figure 3C). Furthermore, p21 is required
for PPARG both to mediate terminal cell differentiation and to
suppress proliferation (Figure 3D). We tested whether PPARG
could regulate p21 expression directly by performing chromatin
immunoprecipitation sequencing (ChIP-seq) experiments, which
revealed significant binding of PPARG to the promoter of p21
during adipogenesis induced by DMI stimulation (Figure 3E).
To further test whether the effect of PPARG on p21 is direct,
we added rosiglitazone, a small molecule that directly activates
PPARG, which led to a robust increase in p21 expression
(Figure 3F).
In the same RNA-seq data, we found that PPARG increases
the expression of FKBPL (WiSP39), a protein that was shown
to stabilize p21 (Jascur et al., 2005) (Figure 3G). To test if p21
could be stabilized by FKBPL during the early stages of adipogenesis, we carried out cycloheximide protein degradation
experiments in cells transfected with siRNA targeting FKBPL.
Our results showed that knockdown of FKBPL causes a small
decrease in p21 half-life but does not affect the half-life of
PPARG, supporting that FKBPL does regulate p21 stability during terminal cell differentiation (Figure 3G). Taken together, our
results demonstrate that PPARG slows, or stops, the cell cycle
during G1 phase by two mechanisms: increasing p21 levels via
increasing p21 transcription and by FKBPL-mediated slowing
of p21 degradation.
Commitment to Terminally Differentiate Triggers
Immediate p21-Driven Cell Cycle Exit
We next focused on the question of how preadipocyte cells
trigger permanent exit from the cell cycle once they pass
the PPARG threshold for terminal differentiation. We took
advantage of the variable increases in PPARG levels between
cells in the population following DMI stimulation and grouped
cells into ten bins according to their expression level of
PPARG at 48 h, right before the DMI-containing medium is replaced with fresh medium without DMI (serum refresh) (Figure 4A). We found that the cells whose PPARG levels stayed
below the threshold (gray lines) proliferated in response to
the serum refresh at 48 h, as measured by an increase in
APC/C reporter signal. However, cells that had passed the
PPARG threshold (blue lines) showed no significant APC/C reporter response, demonstrating that cells that have crossed
the threshold for terminal differentiation lose their ability to

(G) Percentage of differentiated/post-mitotic, undifferentiated/proliferating, and undifferentiated/quiescent cells generated in three independent DMI-induced
differentiation experiments. Cells with PPARG levels above and below the threshold level are defined to be differentiated (PPARG High) and undifferentiated
(PPARG Low), respectively, as described in Figure 1.
See also Figures S2–S4.
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Figure 3. PPARG Directly Upregulates Expression of the CDK Inhibitor p21
(A) Cells transfected with PPARG or control siRNA were stimulated to differentiate by the standard 96 h DMI protocol. The percentage of cells in S/G2/M phases at
each time point is calculated by counting the cells that expressed the APC/C reporter during the 96 h differentiation period divided by the total number of cells. The
percentage of PPARG high cells was assessed by counting the cells with PPARG levels above the threshold divided by the total number of cells at the respective
time point. Approximately 5,000 cells were analyzed per experiment. Representative of three biological replicates.
(B) Wild-type OP9 cells transfected with PPARG or nontargeting siRNA were stimulated to differentiate with DMI. RNA samples were collected every 24 h for
144 h. Bar plots show mean ± 1 SD for three technical replicates.
(C) Dual-reporter cells transfected with p21, p18, or nontargeting siRNAs were stimulated to differentiate with DMI. The number of cell divisions per cell is reported
in the normalized histograms. Representative of two biological replicates.
(D and E) Wild-type OP9 cells were stimulated to differentiate by addition of 1 mM rosiglitazone for 48 h.
(D) p21 levels at different time points were measured by immunocytochemistry. Approximately 5,000 cells were analyzed per experiment. The values of three
technical replicates (points) are plotted on top of the mean (line).
(E) Chromatin immunoprecipitation (ChIP) of PPARG was performed, followed by qPCR. Three sites on the p21 promoter are shown. The promoters of insulin and
Arbp/36b4 served as negative controls, and known PPARG target genes Fabp4/aP2 and Pdk4 were used as positive controls. Data are normalized to a nontargeting genomic site and IgG enrichment. Two-way ANOVA with Bonferroni’s multiple comparisons test was applied for statistical analysis. Values show
mean ± SEM and are representative of two biological replicates. p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
(F) Wild-type OP9 cells were transfected with p21 or control siRNA, stimulated to differentiate by addition of 1 mM rosiglitazone, and analyzed as in (A).
(G) FKBPL expression under nontargeting versus PPARG knockdown were obtained from the RNA-seq data in (B). Data are reported as TPM, mean ± 1 SD.
(H) Wild-type OP9 cells were transfected with FKBPL or nontargeting siRNAs and stimulated to differentiate with DMI. Stability of p21 and PPARG were assessed
by adding 30 mM cycloheximide to the media 24 h after DMI addition and then fixing and staining for protein levels at different subsequent times. Approximately
5,000 cells were analyzed per experiment. Data are plotted as mean ± 1 SD of three technical replicates.
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Figure 4. Cells Simultaneously Commit to Differentiate and Become Locked in a Post-mitotic State by PPARG-Induced Maintenance of High
Levels of p21 Expression
(A) Dual-reporter cells were induced to differentiate using the standard 96 h DMI protocol. Cells were separated into ten bins on the basis of their PPARG levels at
48 h. Plotted lines show mean values for each bin. Inset shows the APC/C reporter signal between 48 and 96 h. Representative of two biological replicates.
(B) Dual-reporter cells were induced to differentiate using the standard 96 h DMI protocol and separated into bins according to their PPARG value before serum
refresh at 48 h. Cells were fixed and stained for p21 levels at the end of the differentiation time course at 96 h. Bins are from 100 to 2,500 a.u. in 100 a.u. increments. The histogram shows the number of cells in each bin. The plotted points show (red) the fraction of cells that had a minimum of one division in response
to the serum refresh at 48 h and (black) the average final p21 level. Representative of two biological replicates.
(C) PPARG, CEBPA, p21, and nontargeting siRNA were transfected into the dual-reporter cells 48 h after DMI addition. siRNA knockdown efficiency is shown in
Figure S5. Representative of three biological replicates.
(D) A similar analysis as described in (A) was performed on the nontargeting and p21-knockdown conditions from (C).
(E) Top: a similar analysis as in (B) was performed on the nontargeting and p21 knockout conditions from (D). Bottom: the same data normalized to the first
PPARG bin.
(F) Images of control and p21-knockdown cells from (C) obtained 48 h after siRNA transfection (96 h). Red arrows indicate representative multi-nucleated cells.
Scale bar, 50 mm.
(G) OP9 cells were induced to differentiate with rosiglitazone. Cyclin D1, p21 and PPARG levels were assessed by immunocytochemistry. Representative of two
biological replicates.
In (A), (B), (E), and (G), the dotted black line shows the PPARG threshold calculated for that experiment.
See also Figure S5.

proliferate
confirmed
divided in
Together,

in response to the serum refresh. We further
this result by calculating the fraction of cells that
response to the serum refresh (Figure 4B, red).
these results argue that crossing the PPARG

threshold marks the time when cells permanently enter a
post-mitotic state.
We next investigated how p21 levels in individual cells change
relative to PPARG levels. We differentiated dual-reporter cells by
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using the standard 96 h DMI protocol and fixed and stained
the cells at the end of the experiment for p21 expression
(Figure 4B, black). We binned the time courses by their PPARG
level at 48 h, which corresponds to approximately the time
when cells decide to differentiate, and found that cells that
had crossed the PPARG threshold at 48 h had high final p21
levels, arguing that p21 is high in cells that terminally differentiate
and is low in cells that fail to differentiate. This result suggests
that an increase in p21 occurs in all differentiating cells and is
responsible for the observed exit to quiescence of differentiating
cells.
To directly test for a role of p21 in suppressing proliferation
after the differentiation threshold has been reached, we used
siRNA to acutely knock down p21 late in adipogenesis at the
48 h time point. As a control, we also knocked down PPARG
and CEBPA, a required co-activator of PPARG expression
that is needed for cells to reach the threshold for differentiation
(Bahrami-Nejad et al., 2018; Wu et al., 1999). Among the three
regulators, only knockdown of p21 resulted in a significant increase in cell cycle activity in the already differentiated cells
(Figure 4C). To quantitatively analyze this result, we binned
cells by their PPARG levels at 48 h (Figure 4D). When control
siRNA is transfected in at 48 h after the differentiation commitment point had been reached in most cells, APC/C reporter signals remain suppressed after serum refresh, even in cells with
PPARG levels above the threshold (siControl, bin 10; Figure 4D,
top panels), consistent with a lack of proliferation. However, in
striking contrast, acute knockdown of p21 expression at 48 h
(sip21, Figure 4D, bottom panels) results in the differentiated
cells being unable to maintain the post-mitotic state. Plotting
the percentage of cells in the cell cycle versus the level of
PPARG further illustrates that if p21 is knocked down, cell divisions cannot be blocked even in cells past the differentiation
threshold with high PPARG levels (Figure 4E). Thus, high p21
is required for differentiated cells to maintain the post-mitotic
state. Furthermore, our findings that PPARG directly increases
p21 levels (Figure 3) and that high PPARG levels become selfsustaining after commitment (Figure 1) explain how p21, which
has a short protein and mRNA half-lives of less than 30 min
(Yang et al., 2017), can be continuously maintained at a high
level in order to keep differentiated adipocytes permanently in
a post-mitotic state. Notably, when we examined images of
cells in which p21 had been depleted late in adipogenesis after
the cells had crossed the PPARG threshold, we found that the
cells were enriched for multinucleation events (Figure 4F). This
result suggests that a critical role of p21 is to permanently prevent cell division after cells have terminally differentiated in order to prevent mitotic defects.
Finally, it was recently shown that the ratio of p21 versus cyclin D1 in the nucleus can predict retinoblastoma (Rb) hyperphosphorylation and re-entry into the cell cycle (Yang et al.,
2017). We determined whether the PPARG-induced increase
in p21 expression shifts the p21/cyclin D1 ratio toward high
p21 in order to keep Rb dephosphorylated and ensure that
cells do not enter the cell cycle when mitogen stimuli increase
cyclin D1 levels. We found that the ratio of p21 to cyclin D1 in
individual cells does become strongly skewed toward p21
when PPARG levels go above the threshold during adipogene-
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sis (Figure 4G), providing an explanation of how differentiated
cells can maintain a robust arrested state. We conclude that
a PPARG-driven rapid differentiation switch is exclusively triggered in G1 to commit preadipocytes to differentiate and that
the same differentiation switch simultaneously triggers permanent cell cycle exit with PPARG first inducing and then maintaining p21 expression.
An Ongoing Competition during G1 between Terminal
Differentiation and Continued Proliferation
The dual-reporter time courses in Figure 2E suggests that there
is a competition that takes place during each G1 phase with two
outcomes: (1) PPARG levels in a cell reach the threshold for differentiation, and proliferation is suppressed, or (2) the cell enters
the next cell cycle, which once again suppresses increases in
PPARG. In addition to this competition, there is also a subset
of cells that remain or go quiescent without participating in the
competition (Figures 2E and 2G). In the cells that compete, G1
phase typically lasts 4 h in proliferating OP9 cells, but differentiating cells typically need at least 14 h in G1 to reach the PPARG
threshold and terminally differentiate (Figures 2F and 5A), which
suggests that cells need to lengthen G1 in order to have a chance
to terminally differentiate. To test for G1 lengthening, we
analyzed dual-reporter time courses and found that the second
G1 length is indeed typically significantly longer (Figure 5B, right;
Figures S6A and S6B). Thus, we conclude that adipogenic stimuli do lengthen G1 and that the lengthening occurs progressively
over multiple cell cycles before cells terminally differentiate out of
the last G1 phase.
As adipogenic stimuli are known to increase the expression of
PPARG and other key adipogenic transcription factors (Rosen
and Spiegelman, 2014), we next tested how this might affect
the competition in G1. Indeed, the longer cells are exposed to
the adipogenic stimuli, as measured by when they had their
last mitosis relative to inducing differentiation, the faster the
cell can reach the PPARG threshold in G1 (Figure 5C). Figure 5D
also shows that the longer a cell is exposed to the differentiation
stimulus, the faster it increases PPARG levels. If a cell had its last
mitosis between 0 and 12 h after DMI addition, PPARG did not
noticeably increase in the subsequent G1. However, a small increase in PPARG can be observed if a cell had its last mitosis
12–24 h after DMI addition, and an even faster increase in
PPARG can be observed if a cell had its last mitosis between
24 and 36 h after DMI addition (Figure 5D). Thus, we conclude
that PPARG increases in G1 phase are initially very slow but
become steeper after 1–2 days of DMI stimulation, which allows
the threshold for differentiation to be reached more quickly during G1.
Taken together, our data show that terminal differentiation of
adipocytes occurs through a competition in G1 (Figure 5E):
When adipogenic stimuli are first applied, preadipocytes initially
proliferate with short G1 periods. Adipogenic stimuli then gradually over time extend G1 length in sequential cell cycles and
also gradually accelerate, during each G1, the rate at which
PPARG increases to the threshold. These two actions help
set up a competition after each mitosis between whether cells
first reach the threshold for differentiation or first enter the next
cell cycle.
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Figure 5. Adipogenic Stimuli Initiate a Competition between the Commitment to Differentiate and Entry into the Next Cell Cycle during a
Gradually Extending G1 Phase
(A) Comparison of the time to commit to the next cell cycle versus time to commit to differentiation in cells that underwent two or three mitoses before differentiating. Right: the end of the second to last mitosis was used as the starting reference time for each cell. Left: histograms comparing the two times measured in
the same cell (data from Figure 2B; n > 4,000 cells, representative of four biological replicates).
(B) Left: schematic showing which G1 periods were compared. Right: histograms of the durations of the first and second G1 periods in cells from (A) that have
undergone at least three divisions. See also Figure S6.
(C) Differentiated cells from Figure 2B were categorized into nine bins on the basis of the time the cell underwent its last mitosis. Plot showing the average time of
the last mitosis versus the average time it took for cells in that bin to increase PPARG levels to the differentiation commitment point.
(D) Differentiated cells from Figure 2B were separated into three groups on the basis of when they last exited mitosis after differentiation stimulus was applied. The
traces were aligned by the last mitosis frame. The median PPARG levels were plotted for each group (dark line). Shaded region represents the 95th confidence
interval. Note that the spike in the PPARG levels at aligned time point 0 is due to aligning the time courses to mitosis. At this time point, there is an undefined
nuclear PPARG signal because the nuclear envelope is broken down and chromatin (H2B) is condensed.
(E) Schematic of the three stages of G1 lengthening in response to adipogenic (DMI) stimuli.
See also Figure S6.

p21 and Cyclin D1 Compete to Regulate the Time When
Cells Commit to Differentiate and Thereby Control the
Number of Terminally Differentiated Cells Produced
Up to this point, we had focused on understanding how adipogenic stimuli regulate cell cycle exit and terminal differentiation.
We next focus on the role of mitogen stimuli. We started by
manipulating the Ras/MEK/ERK signaling pathway, which is
activated by most mitogen stimuli. Indeed, when we added a
MEK inhibitor to cells stimulated cells with DMI (Figure 6A), we
observed as expected that a smaller percentage of cells proliferated and that the time window after stimulation during which
cells kept proliferating was shorter. At the same time, the percentage of cells that terminally differentiated was increased,
and cells committed to terminally differentiate earlier. Similarly,

decreasing the serum concentration along with DMI stimulation
reduced the percentage of cells that proliferated and shortened
the time window after stimulation in which cells could proliferate
(Figure 6B). This was accompanied by an increase in the percentage of terminally differentiated cells, and cells committed
to terminally differentiate earlier.
At first glance, the results in Figures 6A and 6B support the
generally accepted hypothesis that proliferation and terminal differentiation are opposing processes (Ruijtenberg and van den
Heuvel, 2016), and one might therefore expect that mice lacking
p21 or p27 should have more proliferating progenitor cells and
fewer adipocytes. However, one of the most striking findings
from gene knockout studies is that fat tissues of mice with
deleted CDK inhibitors p21 and p27 show a synergistic 6-fold
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Figure 6. Regulation of the Relative Expression of p21 and Cyclin D1 Delays or Accelerates Differentiation Commitment to Control the Total
Number of Differentiated Cells Produced
Dual-reporter cells were differentiated using the standard 96-hour DMI protocol: (A) in the presence of a MEK inhibitor (PD0325091) (representative of two
biological replicates; (B) in normal (10%) and reduced (2%) serum concentrations (representative of two biological replicates); (C) when transfected with p21 or
nontargeting (control) siRNAs (representative of three biological replicates); (D) when stably expressing a DHFR-p21-mCherry fusion protein and in the presence
of 10 mM TMP (to increase expression of p21) or DMSO (control) (representative of two biological replicates); and (E) when transfected with cyclin D1 or nontargeting (control) siRNAs (representative of three biological replicates). Time course data were analyzed as in Figure 3A. Histograms show the total time spent in
G1 phase for each cell trace across all cell cycles for the respective experimental condition. See also Figure S7.

increase in the number of adipocytes with smaller effects in single-knockout mice (Naaz et al., 2004). We used live single-cell
analysis approaches to understand this conundrum that there
are more adipocytes in mice lacking p21 or p27, even though a
loss of p21 or p27 is expected to cause increased mitogeninduced proliferation and thus reduced differentiation.
We first confirmed that cells with knocked down p21 in vitro
spend overall less time in G1 phase and have increased proliferation, consistent with p21 functioning as an inhibitor of proliferation that lengthens G1 (Figure 6C, left). Similar to the effect we
had observed with more mitogen stimulation (Figures 6A and
6B), cells with knocked down p21 also show a delayed commitment to terminally differentiate and can thus have more divisions
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before differentiation (Figure 6C, middle two plots). Furthermore,
the p21-mediated increase in the percentage of proliferating
cells results in a corresponding decrease in the percentage of
differentiated cells (Figure 6C, middle two plots), which can again
be explained by short G1 periods providing less opportunity for
PPARG levels to increase during each G1. Strikingly, despite the
lower percentage of terminally differentiated cells in p21 knockdown conditions, the total number of terminally differentiated
cells significantly increased (Figure 6C, right two plots).
We observed the same seemingly paradoxical positive correlation between proliferation and differentiation when we carried
out p21 overexpression experiments using a DHFR induction
system: the percentage of proliferating cells decreased and the
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percentage of differentiated cells increased, but there was a
lower total number of differentiated cells (Figure 6D). We realized
that the positive correlation between the supposedly opposing
processes of proliferation and differentiation could be explained
by the fact that there is a time window after the differentiation
stimulus during which progenitor cells can still proliferate while
PPARG levels are increasing but still below the threshold value.
However, once cells reach the PPARG threshold and commit to
differentiate, they also shut off the cell cycle (Figure 2E). Thus,
the increase in the total number of terminally differentiated cells
in the p21-knockdown condition can be explained by each progenitor cell with lower p21 undergoing more cell divisions, which
suppresses PPARG increases and therefore causes a delay
when cells reach the threshold to differentiate. Thus, the puzzling
finding of significantly increased adipogenesis and fat mass in
mice lacking p21 or p27 can be explained by an increase in the
number of cells produced per progenitor cell during a longer window of proliferation in cells lacking CDK inhibitors.
As p21 can affect both G1 and G2 phases, we carried out experiments to test when PPARG-mediated p21 increases are
working. We found that the adipogenic DMI stimuli primarily
lengthens G1, rather than S/G2/M (Figure S7A), arguing that
PPARG-mediated p21 expression acts primarily by lengthening
G1 rather than G2. Furthermore, we selectively lengthened S/
G2/M by knocking down CDC25B or CDC25C and did not
observe a noticeable effect on differentiation outcome (Figures
S7B and S7C) (Karlsson et al., 1999).
We found that cyclin D1 knockdown leads to an increase in G1
duration (Figure 6E, left) . Consistent with our model that an increase in G1 duration allows more cells to build up PPARG levels
and differentiate, we observed that the cyclin D1 knockdown reduces the percentage of cells that proliferated, increases the
percentage of terminally differentiated cells, and shortens the
time it takes for cells to terminally differentiate (Figure 6E, middle
two plots). There are also fewer terminally differentiated cells ultimately produced, even though the percentage produced is
higher (Figure 6E, two right plots). Thus, cyclin D1 and p21
have opposing effects in regulating cell cycle exit and terminal
cell differentiation in G1 phase.
Dual Control by the Strength of Mitogen and
Differentiation Stimuli Can Produce More or Fewer
Terminally Differentiated Cells while Maintaining
Similar Pools of Progenitor Cells
Our finding of a molecular competition during G1 phase provides a mechanism for how the number of differentiated cells
may be regulated in a tissue while preserving a similar number
of progenitor cells. Maintaining an adequate of progenitor cells
is important to maintain tissue health and also in the context
when the same progenitor pool is used to make multiple tissue
domains (Ghaben and Scherer, 2019; Sagner and Briscoe,
2019). A progenitor cell induced to differentiate first proliferates, but if it reaches the threshold to terminally differentiate,
it immediately closes the proliferative window and permanently
exits the cell cycle (Figures 7A and 7B). However, if
the commitment to terminally differentiate is delayed, the cell
can continue to divide (i.e., the proliferative window is
extended). These extra divisions before differentiation commit-

ment can lead to more differentiated cells generated per progenitor cell (Figures 7A and 7B).
We propose that a main role of the G1 competition mechanism
we identified is to facilitate a balance between differentiated cells
produced and progenitor cells maintained. As depicted in
Figures 7A and 7B, combined mitogen and differentiation stimuli
may achieve this balance by using G1 competition to regulate if
and when the terminal differentiation switch is triggered and allowing control of the average number of cell cycles before differentiation commitment. Thus, by regulating the duration of G1
phase or by delaying or accelerating the rate at which PPARG
levels reach the threshold to irreversibly differentiate, mitogen
and differentiation stimuli may be able to control the number of
differentiated cells produced while also preserving a similar
number of progenitor cells that do not differentiate.
To test this model that the strengths of both mitogen and adipogenic stimuli are critical for maintaining the progenitor pool
while also regulating the number of terminally differentiated cells,
we performed experiments in which we systematically applied
different relative strengths of adipogenic and mitogen stimuli to
OP9 preadipocyte cells. We then removed the stimulus after
48 h such that we could determine at 96 h the number of cells
that had terminally differentiated versus the number of cells
which remained as undifferentiated progenitor cells. Markedly,
increasing the concentration of mitogens resulted in both larger
numbers of cells kept in the progenitor state (Figure 7C, left) and
larger numbers of differentiated cells generated (Figure 7C,
right), independently of the strength of the also present adipogenic stimulus . In contrast, we observed decreased numbers
of progenitor cells maintained and increased numbers of differentiated cells generated when the strength of the adipogenic
stimulus was increased, independently of the strength of the
mitogen stimulus. In this way, there is a competition between differentiation and mitogen stimuli in G1 whereby the strength of
the mitogen stimulus controls the total number of cells generated
(both progenitor and differentiated), while the strength of the differentiation stimulus controls how many of the total cells remain
progenitor cells or transition to the differentiated state. Taken
together, these titration experiments show that in order to increase the number of differentiated cells produced while maintaining similar numbers of progenitor cells, both differentiation
and mitogen stimuli must increase in tandem. This co-dependence can best be seen in the heatmaps in Figure 7C by manually plotting a contour line that connects differentiation versus
mitogen stimulus conditions that maintained similar numbers
of progenitor cells (Figure 7C, black curved line). The blue and
red dots mark differentiation versus mitogen conditions that produce small and large numbers of terminally differentiated cells,
respectively, while maintaining similar levels of progenitor cells
that remain undifferentiated.
DISCUSSION
We used adipogenesis as a model system to understand how
cells coordinate terminal differentiation and cell cycle exit and
developed a method to measure the precise moment of terminal
differentiation while simultaneously monitoring when cells enter
and exit G1 phase. With this approach, we showed that following
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Figure 7. Mitogen and Adipogenic Stimuli Must Be Simultaneously Regulated in Order to Control the Total Number of Differentiated Cells
Produced while Keeping the Number of Progenitor Cells at Similar Levels
(A) Schematic of how delaying the time to reach the differentiation commitment threshold increases the proliferative window, or time during which progenitor cells
can proliferate before differentiating and becoming post-mitotic. Thus, delaying the time to reach the differentiation threshold increases the total number of
differentiated cells.
(B) Schematic showing how variable numbers of cell divisions before reaching the differentiation threshold can produce significantly different number of terminally
differentiated cells while maintaining similar numbers of progenitor cells. Both scenarios maintain a pool of three progenitor cells (green cells) while producing very
different numbers of differentiated cells (three versus nine).
(C) Combinations of fetal bovine serum (FBS) and DMI stimuli were applied to OP9 preadipocyte cells, and differentiation was measured 96 h later as in Figure 1.
The black line was drawn in manually and marks a contour line connecting stimulus conditions which maintain similar numbers of progenitor cells. As predicted in
the schematics in (A) and (B), manipulating both mitogen and differentiation stimuli synegistically allows for very different numbers of terminally differentiated cells
to be produced while keeping similar numbers of progenitor cells in reserve. The red dot marks conditions which produced approximately three times more
adipocytes than the blue dot conditions, while still maintaining similar numbers of progenitor cells that remain undifferentiated Data shown are representative of
two independent experiments.
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adipogenic stimulation, progenitor cells undergo one or more
cell cycles before they reach a sharp commitment point at which
they terminally differentiate nearly exclusively in G1. We further
show that the underlying rapid PPARG-driven switch mechanism not only commits cells to terminally differentiate but also
rapidly induces expression of the CDK inhibitor p21 to force permanent exit from the cell cycle.
Mechanistically, we show that the rapid increase in p21 is
mediated by PPARG-induced transcription and by expression
of FKBPL and a FKBPL-mediated increase in p21 half-life. The
earlier finding that p21 has a short half-life of less than 1 h at
both the protein and mRNA levels (Figure 3H; Yang et al.,
2017) raises a question common to all terminal differentiation
processes: how can a permanent post-mitotic state be maintained? In adipogenesis, once PPARG levels reach the threshold
for differentiation commitment, the upregulation of positive feedback loops cause PPARG levels to remain high independently of
the input stimulus. These self-sustaining high PPARG levels
permanently induce p21 and thus permanently prevent cells
from re-entering the cell cycle. We also showed that knocking
down p21 after cells have passed the threshold for terminal differentiation re-activates the cell cycle but also results in mitotic
defects, arguing that maintaining high p21 levels after the
commitment to differentiate is critical for cell health. Notably, in
our experiments we plated cells at low density conditions such
that p21 was the dominant CDK inhibitor. At higher cell densities,
the p21 homolog p27 is expected to have a synergistic role
along with p21 in regulating CDK activity and terminal cell
differentiation.
Importantly, our experiments revealed that the length of G1
and number of cell divisions are regulated during the differentiation process by a competition mechanism between cyclin D1
and PPARG-induced expression of p21. This competition during
G1 phase controls whether a cell enters the next cell cycle or
terminally differentiates. At the same time, we found that PPARG
expression is delayed by repression during the S/G2/M period of
the cell cycle and that the self-amplification of PPARG becomes
only gradually sensitized over a 36-h-long time period following
adipogenic stimulation. As a consequence of regulating these
different timing mechanisms, we show that cells delay or accelerate the time when they commit to terminally differentiate,
which in turn controls the number of cell cycles per progenitor
cell and the number of terminal differentiated cells produced
on average from progenitor cells.
Finally, we show that this molecular competition during G1 can
be regulated by the strength of both external adipogenic and
mitogen stimuli and that increasing either stimuli can increase
the number of terminally differentiated cells (Figures 6 and 7;
see also Ahrends et al., 2014; Park et al., 2012). However, adipogenic stimuli increase the number of differentiated cells by
directly depleting the existing number of progenitor cells, while
mitogen stimuli increase the number of differentiated cells by
first generating a large pool of progenitor cells out of which
only a few cells differentiate (Figure 7). This dual control mechanism can explain the conundrum of how mice lacking p21, which
mimics a state of higher mitogen signaling, can have significantly
larger numbers of adipocytes than control mice, despite proliferation and terminal differentiation being opposing processes

(Naaz et al., 2004). Furthermore, we demonstrate that mitogen
and adipogenic stimuli can coordinate a robust terminal differentiation process while ensuring that a pool of progenitor cells is
maintained. Intriguingly, identifying such a mechanism to regulate the balance of progenitor and terminally differentiated cells
is particularly relevant in the context of generating complex organs such as the spinal cord, in which the different neuronal domains along the dorsal-ventral axis are formed through terminal
differentiation of different cell types in a temporal sequence from
the same progenitor pool (Molina and Pituello, 2017; Sagner and
Briscoe, 2019). Not having enough terminally differentiated cells
or an abnormally depleted progenitor pool at any stage in development could lead to deformities and disease.
Together, the opposing roles of cyclin D1 and p21 in regulating
the time when cells commit to terminally differentiate (Figure 6),
and the large in vivo effect of p21 and p27 knockouts on fat mass
(Naaz et al., 2004), suggest that therapeutic strategies aimed at
regulating the time when cells commit to terminally differentiate
may prove useful to control the size of terminally differentiated
tissues. For example, as DNA damage and aging increase p21
expression, such conditions may cause an imbalance between
progenitor and differentiated cells and may result in insufficient
fat and other terminally differentiated cells produced through
this competition mechanism. It is suggestive to propose that
our finding may represent an example of a more general control
principle whereby the size of tissues may generally be regulated
by a competition between cyclins on one side and drivers of terminal cell differentiation and CDK inhibitors on the other side.
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RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Mary
N. Teruel (mnt4002@med.cornell.edu).
Materials Availability
Further information and requests for reagents may be directed to, and will be fulfilled by Dr. Mary N. Teruel.
Data and Code Availability
MATLAB analysis scripts and datasets used in this paper are available on Medeley Data at the following: https://doi.org/10.17632/
n9r24r9tdb.1
EXPERIMENTAL MODEL AND SUBJECT DETAILS
The OP9 mouse stromal cell line (ATCC CRL-2749) used in this manuscript was established from newborn op/op mouse calvaria and
are classified as being from bone marrow/stroma tissue and of an embryonic stem cell/macrophage cell type. The OP9 cells were
maintained according to protocols described in Bahrami-Nejad et al. (2018) and Wolins et al. (2006).
METHOD DETAILS
Generation of PPARG and APC/C dual-reporter cell line
OP9 cells with endogenously tagged citrine-PPARG2 and stably infected H2B-mTurqoise were generated as previously described
(Bahrami-Nejad*, Zhao*, et al., 2018). To make dual reporter cells, a lentiviral strategy, outlined below, was used to stably introduce
the APC/C reporter into the citrine-PPARG2 cell line.
Lentiviral production was carried out using a third-generation lentiviral packaging system that consisted of the following packaging
vectors: pMDlg, pCMV-VSVG, and pRSV-Rev and the lentiviral vector with the APC/C reporter, pCSII-EF-Geminin(1-110)-mCherry.
The vectors were transfected into (12 mg pMDlg, 6 mg pRSV-Rev, 3 mg pCMV-VSVG, 6 mg lentiviral vector of interest) HEK293T
growing in Opti-MEM with Lipofectamine 2000 using the manufacturer’s suggested protocol. HEK293T cells were seeded one
day before transfection at a density of 5x106 cells in a collagen treated 10 cm cell culture dish. The transfection media was removed
after one day and replaced with 7 mL of fresh Opti-MEM. Viral particles were collected over two days by collecting the supernatant
and replacing it with fresh Opti-MEM every day. The final supernatant (total volume 14 mL) was then filtered through a 0.45 mm filter
to remove cellular debris and then concentrated using Amicon Ultra-15 Centrifugal Filter tubes with a 100,000 kDA molecular weight
cutoff (EMD Millipore) spun at 3,300 rcf. for 30 minutes. Concentrated viral supernatant was then aliquoted into four or five cryogenic
freezing tubes containing 40 mL each for storage at 80 C.
To infect cells with lentivirus, OP9 cells were first seeded at a density of 50,000 cells per well of a 6 cm cell culture plate. One aliquot
of concentrated viral supernatant was mixed in 2 mL of MEM-a media (ThermoFisher Scientific) containing 100 units/mL Penicillin,
100mg/mL Streptomycin, and 292 mg/mL L-glutamate supplemented with 10% FBS. Polybrene was added at a concentration of
7 mg/mL to facilitate infection efficiency. After one day, infection medium was changed to fresh growth medium (MEM-a media (ThermoFisher Scientific) containing 100 units/mL Penicillin, 100mg/mL Streptomycin, and 292 mg/mL L-glutamate supplemented with
20% FBS). Upon reaching confluence, infected cells were trypsin detached and seeded in larger T75 flasks for expansion prior to
sorting. After two days of growth, cells were trypsin detached and submitted for FACS sorting to obtain a population of APC/C sensor
positive cells marked by positive mCherry fluorescence.
Generation of a PPARG, APC/C activity reporter, and CDK2 triple reporter cell line
Lentivirus was generated for the CDK2 sensor from the vector pCSII-EF-DHB-mTurquoise (gift from the lab of Tobias Meyer) in the
same manner described above and used to infect cells expressing citrine-PPARG, APC/C activity reporter (mcherry), and H2BiRFP670 (far red) cells. Selection of triple-reporter cells was done by FACS sorting for cells that were positive for both mCherry
and mTurquoise.
Generation of a PPARG and CRL4-CDT dual reporter cell line
The CRL4-Cdt2 construct was developed by Atsushi Miyawaki’s lab (Sakaue-Sawano et al., 2017) and was obtained from the lab of
Tobias Meyer. We changed the fluorescent tag to iRFP670 and generated lentivirus in the same manner described above. Selection
of triple-reporter cells stably expressing iRFP670-CRL4-Cdt2 was done by FACS sorting for cells that were positive for both mCherry
and iRFP670.
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Cell culture and differentiation
Wild-type and reporter OP9 cell lines were cultured according to previously published protocols (Ahrends et al., 2014; BahramiNejad et al., 2018; Wolins et al., 2006). Briefly, the cells were cultured in growth media consisting of MEM-a media (ThermoFisher
Scientific) containing 100 units/mL Penicillin, 100mg/mL Streptomycin, and 292 mg/mL L-glutamate supplemented with 20% FBS.
To induce differentiation, two methods were used. The first method is the standard 96-hour DMI protocol commonly used to
induce adipogenesis (Bahrami-Nejad et al., 2018; Wu et al., 1999). An adipogenic cocktail (DMI) consisting of dexamethasone
(1 mM, Sigma-Aldrich), IBMX (125 mM, Sigma-Aldrich), and insulin (1.75 nM, Sigma-Aldrich) is added to the cell media for 48 hours,
and then aspirated and replaced with fresh media containing 1.75 nM insulin for another 48 hours. In the second method, 1 mM of
Rosiglitazone (Cayman, USA) is added to the cell media for 48 hours, and then aspirated and replaced with fresh media containing
1.75 nM insulin for another 48 hours. For fixed cell experiments, the media consisted of the growth media described above with
one modification: 10% FBS was used (instead of 20% FBS) during differentiation conditions. The one exception is the reduced
serum experiments in Figure 4D, in which 2% FBS was used in the growth media during differentiation. For all live cell experiments, the differentiation stimuli were added to Fluorobrite DMEM media (ThermoFisher Scientific) containing 100 units/mL Penicillin, 100mg/mL Streptomycin, and 292 mg/mL L-glutamate supplemented with 10% FBS. The MEK inhibitor PD0325091 was
used at a final concentration of 100 nM.
In our experiments, we purposely used sub-confluent cell plating conditions in order to maximize the number of cell divisions, to
reduce the effect of cell density on cell cycle arrest, and to improve the fidelity of the automated tracking algorithm (Figures S3A and
S3B). Because we plated cells at low density conditions, p21 was the dominant CDK inhibitor. At higher cell densities, the p21 homolog p27 is expected to have a synergistic role along with p21 in regulating CDK activity and terminal cell differentiation. Such a
synergistic role of both CDK inhibitors is consistent with knockout data in mice which showed a 6-fold increase in fat mass when
p27 and p21 were knocked out together as compared to smaller increases with only individual knockouts (Naaz et al., 2004).
siRNA-mediated gene silencing
siRNA targeting Pparg, Cebpa, p21, CyclinD1, Fkbpl and the AllStars Negative Control siRNA were purchased from QIAGEN. For
siRNA knockdown in the live-cell imaging experiments in dual-reporter cells (Figures 4, 5A, 5D, and 5E), OP9 cells were transfected
by reverse-transfection using mL Lipofectamine RNAiMax (Invitrogen). Briefly, our reverse-transfection protocol per well is as follows:
mixed 20 mL of Optimem, 0.5 mL of a 10 mM siRNA stock solution, and 0.3 mL of RNAiMax. Let solution incubate at room temperature
for 10 minutes and then add 80 mL of culture media containing the desired number of cells per well. Then the entire (100mL) volume is
plated into one well of a 96-well plate. The siRNA/RNAiMax mixture was left on the cells for 24 hours before being aspirated away and
replaced with fresh culture media containing DMI to begin the differentiation protocol.
For the live-cell imaging experiments in dual-reporter cells transfected at the 48-hour time point (Figure 6), the following protocol
per well was used: siRNA mixture was prepared using 0.6 mL Lipofectamine RNAiMAX, 0.5 mL of a 10 mM siRNA stock solution, and
20 mL of Optimem. Incubate the mixture for 10 minutes then add 180 mL of Fluorobrite media consisting of 1.75 nM insulin. The entire
solution (200mL total volume) was then added to cells at the 48-hour time point and left on until the end of the experiment.
Overexpression of p21
A retroviral vector containing DHFR-Chy-p21(Spencer et al., 2013) (gift from the lab of Tobias Meyer) was used to generate viral particles to stably infect DHFR-Chy-p21into a modified dual-reporter cell line. This cell line was also stably infected with H2B-iRFP670
and a version of the APC/C reporter fused to mCerulean3. Positive clones were selected for by FACS in cell culture media containing
10 mM TMP. Cells were sorted into culture media with no TMP and grown in the absence of TMP. All overexpression experiments
were done by adding 10 mM TMP into the culture media or differentiation media. In control experiments, 10 mM DMSO was added
instead of TMP.
Immunofluorescence (IF) staining
All cultured cells were fixed with 4% PFA in PBS for 30 min at room temperature, followed by five washes with PBS using an automated plate washer (Biotek). Cells were then permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at 4 C, followed by blocking
for 1 hour in 5% bovine serum albumin (BSA, Sigma Aldrich) in PBS. The cells were incubated with primary antibodies in 2% BSA in
PBS overnight at 4 C: mouse anti-PPARg (Santa Cruz Biotech, sc-7273, 1:1,000), rabbit anti-CEBPa (Santa Cruz Biotech, sc-61,
1:1,000), mouse anti-p21 (Santa Cruz Biotech, sc-6246, 1:100), cyclinD1 (Abcam, ab137145,1:1,000), adiponectin (Abcam,
ab22554, 1:1,000), Glut4 (Santa Cruz Biotech, sc-1608,1:500), FABP4 (R&D Systems, AF1443, 1:1,000). After washing, cells were
incubated with Hoechst (1:20,000) and secondary antibodies in 2% BSA / PBS for 1 hour. Secondary antibodies included AlexaFluor-conjugated anti-rabbit, anti-mouse, and anti-goat antibodies (Thermo Fisher Scientific). All secondary antibodies were used
at a 1:1,000 dilution. Where indicated, neutral lipids were measured by adding HCS LipidTOX Deep Red Neutral Lipid Stain 637/
655 (1:1,000), ThermoFisher Scientific H34477) to secondary antibody solution. Cells were washed five times with PBS in an automated plate washer prior to imaging. For fixed-cell time course experiments, approximately 7,000 wild-type or dual-reporter OP9
cells were used to calculate mean values at each time point for each technical replicate.
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RNaseq
siRNA targeting Pparg (# L-040712-00-0005) and Negative Control siRNA (# D-001810-10-05) were purchased from Dharmacon and
transfected into OP9 cells using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer’s protocol. siRNA was used at a
concentration of 25 nM, and the RNAiMAX/siRNA mixture was applied for 48 hours prior to the induction of differentiation. For gene
expression analysis of OP9 cell samples, the cells were differentiated for 144 hours using a previously described protocol (Ahrends
et al., 2014). RNA from three independent biological experiments were collected at different time points before and after induction of
differentiation including (d0-d6) the extraction was completed using RNeasy Mini Kit (QIAGEN, Cat. 74104). RNA quality of all samples (n = 7 time points and n = 3 experiments from independent passages) was evaluated by both Nanodrop for (A260/280 > 2) and
Bioanalyzer 2100 High Sensitivity RNA Analysis chips (Agilent, Cat. 5067-1513) which displayed intact RNA integrity (RIN > 9). mRNA
samples were concentrated to % 5 ml by MinElute column (QIAGEN, Cat. 74204). For generation of RNA-seq libraries, polyadenylated
mRNA was isolated from 300 ng of total RNA by incubation with oligo-DT attached magnetic beads and followed by strand-specific
library preparation using the TruSeq Stranded mRNA Library Preparation kit (Ilumina, Cat. 20020595). Briefly, isolated polyadenylated mRNA was fragmented using divalent cations under elevated temperature and 1st and 2nd strands DNA were synthesized using
SuperScript II Reverse Transcriptase (provided with Ilumina kit). A-tailing and adaptor ligation was performed according to the manufacturer’s protocol; the resulting dsDNA was enriched in a PCR reaction based on predetermined CT values and cleaned using
AMPure XP beads (provided with Ilumina kit). Concentrations of enriched dsDNA fragments with specific adapters were determined
and base pair average size as well as library integrity were analyzed using the Bioanalyzer DNA High Sensitivity chips (Agilent, Cat.
5067-4626). Samples were pooled and sequenced on the Illumina NextSeq 500/550 High Output platform (Illumina, FC-404-2002) up
to 18 samples per lane with 1% PhiX spike as a control.
The read quality of the raw FASTQ files was checked with FastQC (Andrews, 2010) (v0.11.7). Next, reads were pseudo-aligned to
the mouse reference transcriptome (Mus_musculus.GRCm38.cdna) using Kallisto(Bray et al., 2016) (v0.44.0) with the quantification
algorithm enabled, the number of bootstraps set to 100, and run in paired-end mode. The Kallisto output files were read into R using
Sleuth, and the transcripts per million (TPM), a measurement of the proportion of transcripts in the RNA pool, was used for downstream differential expression analysis(Pimentel et al., 2017).
Measuring protein decay rates using cycloheximide
Protein decay rates were quantified as previously described(Bahrami-Nejad et al., 2018). Briefly 10,000 OP9 cells were seeded in 96well plates) one plate for each time point. Cells were induced to differentiate with DMI for 24 hours. Cyclohexamide was added to the
media at a final concentration of 30 mM. Cells were fixed and stained at different times after addition of cyclohexamide, and immunofluorescence was used to quantify protein concentration. Half-lives were obtained by fitting first order exponential decay curves to
the data.
Fluorescent imaging
Imaging was conducted using an ImageXpress MicroXL (Molecular Devices, USA) with a 10X Plan Apo 0.45 NA objective. Live fluorescent imaging was conducted at 37 C with 5% CO2. A camera bin of 2x2 was used for all imaging condition. Cells were plated in
optically clear 96-well plates: plastic-bottom Costar plates (#3904) for fixed imaging or Ibidi m-Plate (#89626) for live imaging. Living
cells were imaged in FluoroBrite DMEM media (Invitrogen) with 10% FBS, 1% Penicillin/Streptomycin and insulin to reduce background fluorescence. Images were taken every 12 min in different fluorescent channels: CFP, YFP and/or RFP. Total light exposure
time was kept less than 700 ms for each time point. Four, non-overlapping sites in each well were imaged. Cell culture media were
changed at least every 48h.
QUANTIFICATION AND STATISTICAL ANALYSIS
Imaging data processing
Data processing of fluorescent images was conducted in MATLAB R2016a (MathWorks). Unless stated otherwise, fluorescent imaging data were obtained by automated image segmentation, tracking and measurement using the MACKtrack package for MATLAB. Quantification of PPARG- and CEBPA-positive cells in fixed samples was based on quantification of mean fluorescence signal
over nuclei. Cells were scored as PPARG- and CEBPA-positive if the marker expression level was above a preset cut-off determined
by the bimodal expression at the end of the experiment.
For live imaging data of OP9 cells, the CFP channel capturing H2B-mTurqoise fluorescence was used for nuclear segmentation
and cell tracking. Obtained single-cell traces were filtered to removed incomplete or mistracked traces according to the following
criteria: cells absent within 6 hours of the endpoint, cell traces that started more than 4 hours after the first time point, cells that
had large increase or decrease in PPARG intensity normalized to the previous time point, cells where H2B drops did not match drops
in the APC/C reporter. If cells were binned according to their PPARG expression, cells were binned based on their mean nuclear
PPARG expression at the described time points.
The percent of cells in the S/G2/M phases at each time point is calculated by counting the cells that expressed the APC/C reporter
during the 96-hour differentiation period divided by the total number of cells. The percent of PPARG high cells was assessed by
counting cells that above the PPARG threshold at that time point and dividing by the total number of cells at that time point.

e4 Cell Reports 31, 107769, June 16, 2020

ll
Article

OPEN ACCESS

Estimating a differentiation commitment point (i.e., PPARG threshold)
PPARG values at the end of a differentiation experiment typically exhibit a bimodal distribution. In order to estimate a commitment
point, PPARG values at the last frame of the experiment was fit to a 2 component Gaussian mixture model. Cells were then classified
as either differentiated or undifferentiated based on whether they more closely associated with the high or low component of the
mixture model, respectively. The commitment point was then assessed as the value of PPARG at the 48-hour time point, before
the stimuli was removed, that predicted the final differentiation classification with a false positive rate of less that 5%. In experiments
where multiple conditions are present, the Gaussian mixture model was only fitted to the negative control and the commitment point
was selected based on the negative control model and applied to all other conditions in the same experiment.
Note that the early in adipogenesis before cells reach the threshold, PPARG levels are not correlated with endpoint measurements
of adipocyte markers (Figure 1G). However, once the threshold was reached, PPARG levels sharply switch to being positively correlated, supporting that crossing the PPARG threshold marks a short time window of PPARG self-amplification that causes an irreversible commitment to the future terminally differentiated adipocyte state (see also Figure S1D). Notably, without aligning time courses to
a threshold, we would only see that there is an increased probabilistic relationship between PPARG expression and mature adipocyte
markers; for example, see rightmost plot in Figure 1G which shows a gradual increase in correlation with PPARG with GLUT4 when
time courses are not aligned by the threshold. Thus, without being able to measure a threshold for each cell and being able to align the
PPARG time course for each cell by this threshold, we would be unable to mark a precise time point for differentiation commitment, as
can be seen when comparing the aligned and unaligned plots in Figures 1G and S1E.
Statistics
Unless specified otherwise, data are expressed as mean ± standard error of the mean (SEM). Live traces are expressed as median ±
interquartile range (25th-75th percentiles). For histograms with a y axis labeled ‘‘Fraction of Cells,’’ each histogram (not each plot) is
normalized to the total number of cells in the population of that histogram such that all bars in the histogram add to 1. Representative
results are representative of at least two independent experiments.
Data availability
All relevant data from this manuscript are available upon request.
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Figure S1. Additional validation of citrine-PPARG as a marker of differentiation commitment, Related to Figure 1.
(A)The PPARG derivative and integral values are poorer predictors of differentiation, Traces from Figure 1B were smoothed using a
Butterworth filter and a five-point stencil was applied to the smoothed traces to estimate the PPARG derivative at each timepoint.
The PPARG derivative traces were then analyzed in a similar manner as in Figure 1E. Bins range from -300 to 300 in intervals of 50.
(B) The PPARG integral at each time point was estimated using the trapz() function in MATLAB (MathWorks). The integral values
were then analyzed in a similar manner as described in Figure 1E. The bins range from 0 to 5x105 in intervals of 104. Note that both
the derivative and integral are poor predictors for the final differentiated state. In the case of the derivative, the range between the
lowest predicted probability and the highest predicted probability is smaller than found in Figure 1E. The integral values, although a
good predictor for a single time point, suffers from the lack of consistency across timepoints, and a single integral value cannot be
used to separate undifferentiated and differentiated cells for all timepoints.
(C) The analysis in Figure 1E was done for more time points that span the duration of the experiments and presented as a heatmap
where rows represent a timepoint and the columns represents the PPARG bins as described in Figure 1E. The dotted line represents
the estimated PPARG threshold for the experiment. The expanded analysis shows that the PPARG threshold remains stable
throughout the experiment.
(D) The switch from PPARG low to PPARG high occurs over a relatively short time window. Blue traces represent unaligned
population medians of the PPARG abundance (top) and PPARG derivative (bottom). The red trace represents the PPARG abundance
(top) and PPARG derivative (bottom) after computationally aligning all traces by the time when the PPARG threshold is crossed and
is represented by the zero timepoint. The dashed lines highlight the time window around the peak in the PPARG derivative of the
aligned traces and suggests that the switch between PPARG low and PPARG high states occurs over a short window of about 4
hours. All shaded regions represent the interquartile range (25th-75th percentiles).
(E) Unaligned correlations of endpoint markers of adipogenesis to PPARG over a typical 4-day DMI differentiation experiment.
PPARG timecourses from the cells that differentiated after 96 hours in Figure 1D were averaged. At each time point, the Pearson
correlation coefficient between the unaligned PPARG values, and the endpoint immunofluorescence values for adipocyte markers
was calculated. Without being able to measure a threshold for each cell and being able to align the PPARG timecourse for each cell
by this threshold, we would be unable to mark a precise timepoint for differentiation commitment, as can be seen when comparing
the aligned and unaligned plots in Figures 1G and S1E.
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Figure S2. The APC/C reporter behaves similarly to the Crl4-Cdt2-based sensor in marking the start of S-phase in OP9 cells,
Related to Figure 2.
(A) Dual reporter cells infected with a Crl4-Cdt2 reporter tagged with iRFP670. Cells were stimulated to differentiate using the
standard DMI 96-hour differentiation protocol, and timecourses from individual cells are plotted to compare the dynamics of the
APC/C reporter and Crl4-Cdt2 sensor.
(B) Comparison of median levels of the APC/C and Crl4-Cdt2 reporter with t=0 marking the onset of S phase. Shaded regions represent the interquartile range (25th to 75th percentiles).
(C) Comparison of the median levels of APC/C and Crl4-Cdt2 reporters at the onset of S-phases across multiple days of imaging.
Shaded regions represent the interquartile range.
(A-C) In summary, in our manuscript, we used the APC/C reporter although the Crl4-Cdt2-based sensor is thought to provide more
accurate measurements of G1 duration (Matson et al, eLife 2017, PMID: 29148972 ). We found that the difference between the two
probes in measuring the G1/S transition is only on the order of 1-2 hours at most in OP9 cells, which supports that the APC/C reporter
is accurately measuring G1 duration in the OP9 cells used in this manuscript.
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Figure S3. Additional results, Related to Figure 2.
(A) Characterization of the plating conditions. In this study, we used subconfluent plating conditions (5K per well) instead of
plating at confluent (15K per well) conditions that we normally use. Subconfluent plating increases the number of cell division
events observed during adipogenesis and allows for easier cell tracking. The dual reporter cells were differentiated using the
standard DMI cocktail. Left, The plot represents the fraction of cells that are considered past the PPARG threshold at each time
point for both cell density conditions. Right, A comparison of the fraction of dual reporter cells in S/G2/M phases of the cell
cycle, as assessed by the APC/C reporter, for both plating conditions.
(B) The number of mitotic events for both plating conditions are reported in the histogram as the fraction of cells observed with
a given number of mitosis events. The 15,000 cells per well plating condition represents a standard differentiation protocol and
yields high rates of differentiation and relatively low cell cycle activity. However, plating cells at a density of 5000 cells per well
leads to a lower degree of differentiation and a higher degree of cell cycle activity. The live cell experiments in this manuscript
are plated at a density of 5000 cells per well.
(C) Dilution through cell division does not significantly affect PPARG dynamics in differentiated cells. PPARG dynamics in
differentiated cells were compared between cells that divided two (blue) or three (red) times in the span of the experiment, as
indicated by the APC/C reporter (right). Additionally, the selected cells all completed the last mitosis at similar times. PPARG
(left) and APC/C reporter (right) traces were computationally aligned to the last mitosis time. Bold traces represent median
values and the shaded region represents the 95th confidence interval of the median.
(D) The trade-off between continued proliferation and differentiation exists even in cells that have been selected for undergoing
exactly two divisions during the timespan of a 96-hour live-cell experiment.
(E) A CDK2 sensor (orange trace) was added to the PPARG and APC/C dual reporter cells to create triple reporter cells. Triple
reporter cells were differentiated using the standard DMI protocol, and a representative trace is shown. The yellow dot
represents the time when the cell reached the PPARG threshold and irreversibly committed to the differentiated state. Representative of 2 independent experiments.
(F) Scatter plot showing the CDK2 activity versus PPARG level in each single cell at every time point. The red dashed line
represents the PPARG threshold.
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Figure S4. Significant cell-to-cell variability is apparent even accounting for factors such as cell cycle phase when DMI
was added, number of previous cell cycles, and refreshing the stimulus/serum, Related to Figure 2.
(A) Plot shows cells that differentiated in the experiment separated by what phase of the cell cycle the cells were in when
DMI was added. Cells in which the adipogenic stimulus is added in G1 have fewer average additional divisions compared to
cells where adipogenic stimuli are applied in S/G2/M.
(B) Analysis of the PPARG increase in cells with 0, 1 or 2 divisions before terminal cell differentiation.
(C) When the time of second mitosis is late, cells have on average slower increases in PPARG compared to cells where
the second mitosis is earlier.
(D) Control experiment showing that replacement of DMI medium every 12 hours does not significantly change differentiation
outcome.
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Figure S5. Validation of the siRNA knockdown efficiency when cells were transfected at 48 hours after induction of
adipogenesis, Related to Figure 4.
(A) Cells were transfected with siRNA 48 hours after addition of the adipogenic DMI stimulus and knockdown efficiency was
assessed 48 hours later (at the end of the 96-hour long time-lapse experiment). To validate the siRNA knockdown efficiency of
p21 and CEBPA, cells were fixed with paraformaldehyde and immunostained for p21 or CEBPA levels.
(B) Validation of the cyclin D1 antibody by siRNA knockdown. Cells were transfected with non-targeting siRNA or cyclin D1
targeting siRNA for 24 hours and then fixed and stained for cyclin D1 levels, mean (bold line) and 95th confidence interval
(shaded region).
(C) This comparison compares the effect of adding siRNA at the 48 hours after DMI to our regular protocol (in support of
Figure 4). It shows that our protocol does not have a significant affect on differentiation or cell cycle outcomes.
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Figure S6. Adipogenic stimuli initiate a competition between proliferation and differentiation during a gradually extending
G1 phase, Related to Figure 5
(A) Histogram of the difference between G11 and G12 for each cell from Figure 5B.
(B) Plot of G1 duration versus how long a cell had been exposed to the adipogenic (DMI) stimulus at the start of G1 for each cell
from (A). Red line marks average G1 duration of all cells.
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Figure S7. Effect of regulating G2 duration on adipogenesis and proliferation, Related to Figure 6.
(A) Analysis of timecourses in Figure 2B showing duration of G1 versus S/G2/M for differentiated and undifferentiated cells.
Representative of 3 independent experiments.
(B-C) Analysis of timecourses of OP9 cells transfected with siRNA targeting cdc25c and cdc25c and induced to differentiate using
a standard DMI protocol.

Target

Catalog no.

Target sequence

(Qiagen)
CCND1

SI00943649

CTGCATGTTCGTGGCCTCTAA

CCND1

SI00943642

TAGGGATGAAATAGTGACATA

CCND1

SI00943635

CAGAAGAGTATTTATGGGAAA

CDKN1A (p21)

SI02652524

ACCGTGGGTGTCAAAGCACTT

CDKN1A (p21)

SI02652517

CCGGAACATCTCAGGGCCGAA

CDKN1A (p21)

SI02652510

CTCTGTGTGTCTTAATTATTA

CDKN1A (p21)

SI02652503

TCCAAACTTAAAGTTATTTAA

CEBPA

SI00948311

AAGAGCCGAGATAAAGCCAAA

CEBPA

SI00948318

CGGCCGCTGGTGATCAAACAA

CEBPA

SI00948325

CAACGTGGAGACGCAACAGAA

FKBPL

SI01003380

CCGGGCCATTTAAAGGCCTTA

FKBPL

SI01003373

CAAGATGTTTAGCTGATTAAA

FKBPL

SI01003366

CAGACTGGATTCCTTCACCAA

FKBPL

SI01003359

AGGCCTCAACATCATACACAA

PPARG

SI01385391

CTCGCATTCCTTTGACATCAA

PPARG

SI01385398

AACCTTGATTTGAATGACCAA

PPARG

SI01385405

GAGGGCGATCTTGACAGGAAA

Table S1: siRNA sequences used in gene knockdown experiments, Related to Figures 3, 4, and 6.
Knockdown experiments were performed using pools of 4 commercially available siRNA sequences.
Individual siRNA species targeting the same gene were pooled together before each experiment.

